Swiss investment firm Sectoral Asset Management has launched a new biotech strategy, the Variopartner SICAV – Sectoral Biotech Opportunities Fund with initial assets of over $50m (€44.1m). The fund invests in innovative biotech companies and focuses on small and mid caps. Its portfolio consists of 30 high conviction positions and the stock selection applies a bottom-up approach. […]
Irene Campos of Inverdif Asesores on how fine art is adding diversification in the fund environment
Enrique Pardo of Allfunds Bank on the European welcome to non-European managers
Stefan Keil of NORD/LB on the duration challenge to selection
Miguel Ángel Olmeda of Bank Degroof Petercam Spain comments on the challenge of closet tracker funds
Loading ...
Beating the S&P 500 is possible 
Sean Flanagan to attend Hamburg Summit 
Anthony Cross to attend Hamburg Summit 
Luis Fañanas of JOHCM reviews European large caps at Copenhagen Forum 
Lars Jaeger of GAM addresses alt risk premia at Copenhagen Forum 
Kyle Kloc of Fisch AM tackles global HY at Copenhagen Forum 